Shionogi & Co Ltd (SGIOF) Q3 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, everyone. My name is Kyokawa from Public Relations Department of Shionagi. Thank you very much for joining us today. This is the briefing for the financial result of the Q3 of fiscal year 2023. From Shionagi today, we have Dr. John Keller, Senior Executive Officer, Senior Vice President, Supervisory Unit. And then we have Dr. Iwasaki, Senior Executive Officer, Senior Vice President, Healthcare Business Supervisory Unit in Pharmaceutical Commercial Division. And then Dr. Ryuichi Kiyama, Senior Executive Officer, Senior Vice President, Corporate Strategy. And then Dr. Uehara, a corporate office, a senior vice president, and then we have Masako Kudo, vice president, finance and accounting department. Today, Kudo is going to brief you on the financial results for the Q3, and then Dr. Kiyama is going to explain our undertaking for the future growth. Then we'll have Q&A session. We are planning to end the session at 4 o'clock. Now let me explain simultaneous translation. Simultaneous translation is available for this session today. If you wish to use simultaneous translation, please click the globe icon at the bottom of your screen and choose either Japanese or English. Now let us start, Kudo-san. My name is Kudo. I'll give you the briefing of the financial result of Q3 and the amendment of the forecast. Now page 4. This is the actual. The 338 billion for revenue with the profit operating profit of 146 billion. And then the net profit 198 billion. As to the Koba, we booked 100 billion for the Koba. And for base business, it's been going very well. So as you can see at the right, as you can see, the revenue and other profit categories are achieving higher figures as compared to the previous year. This time we are indicating how many times we've increased our revenue ...